HYDROFARM HOLDINGS GROUP, INC. (HYFM) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 733.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -268.75M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $733.00K | $-268.75M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | $872.00K | $-274.66M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $134.25M | $1.18M | $-276.92M | (m) | (m) | 0.88% | (m) | (m) |
| 2025-09-30 | (m) | $146.44M | $1.06M | $-52.41M | (m) | (m) | 0.72% | (m) | (m) |
| 2025-06-30 | (m) | $161.10M | $1.52M | $-48.49M | (m) | (m) | 0.94% | (m) | (m) |
| 2025-03-31 | (m) | $176.65M | $2.01M | $-54.47M | (m) | (m) | 1.14% | (m) | (m) |
| 2024-12-31 | (m) | $190.29M | $2.38M | $-52.18M | (m) | (m) | 1.25% | (m) | (m) |
| 2024-09-30 | (m) | $200.16M | $3.35M | $-48.48M | (m) | (m) | 1.67% | (m) | (m) |
| 2024-06-30 | (m) | $210.32M | $3.70M | $-55.68M | (m) | (m) | 1.76% | (m) | (m) |
| 2024-03-31 | (m) | $218.57M | $4.75M | $-45.35M | $15.68M | (m) | 2.17% | -2.89× | Reported |
| 2023-12-31 | (m) | $226.58M | $5.08M | $-49.70M | $15.44M | (m) | 2.24% | -3.22× | Reported |
| 2023-09-30 | (m) | $240.86M | $5.73M | $-64.95M | $14.52M | (m) | 2.38% | -4.47× | Reported |
| 2023-06-30 | (m) | $260.85M | $6.37M | $-69.04M | $13.63M | (m) | 2.44% | -5.07× | Reported |
| 2023-03-31 | (m) | $295.30M | $6.63M | $-268.25M | $12.28M | (m) | 2.24% | -21.84× | Reported |
| 2022-12-31 | (m) | $344.50M | $8.35M | $-281.60M | $10.96M | (m) | 2.42% | -25.70× | Reported |
| 2022-09-30 | (m) | $393.45M | $8.33M | $-263.93M | $9.72M | (m) | 2.12% | -27.14× | Reported |
| 2022-06-30 | (m) | $443.12M | $7.89M | $-246.02M | $6.78M | (m) | 1.78% | -36.26× | Reported |
| 2022-03-31 | (m) | $479.41M | $6.91M | $-35.48M | $4.41M | (m) | 1.44% | -8.04× | Reported |
| 2021-12-31 | (m) | $479.42M | $5.01M | $-2.70M | $2.14M | (m) | 1.04% | -1.26× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $342.20M | $8.89M | $4.28M | $10.14M | (m) | 2.60% | 0.42× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $235.11M | $208.00K | $-26.73M | $13.47M | (m) | 0.09% | -1.99× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NATURAL HEALTH TRENDS CORP (NHTC) | United States | $0.009B | |
| EDUCATIONAL DEVELOPMENT CORP (EDUC) | United States | $0.011B | |
| Vestis Corp (VSTS) | United States | $1.828B | -356.33 |